GRANOCYTE 34
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
LENOGRASTIM 33.6 MIU/ML
Available from:
SANOFI - AVENTIS ISRAEL LTD
ATC code:
L03AA10
Pharmaceutical form:
LYOPHILIZED POWDER FOR INJECTION
Administration route:
I.V, S.C
Manufactured by:
SANOFI WINTHROP INDUSTRIE, FRANCE
Therapeutic group:
LENOGRASTIM
Therapeutic indications:
- Reduction in duration of neutropenia and associated complications in patients undergoing bone marrow transplantation or cytotoxic chemotherapy associated with a febrile neutropenia. - Autologous mobilization of Peripheral Blood Progenitor Cells. As an adjunct to allogenic mobilization of peripheral blood progenitor cells (PBPCs).
Authorization date:
2011-12-01
